Matic and Catalyst Health Group Named D CEO Finalists for Healthcare Collaboration, Rebuilding the Primary Care Physician Day and Restoring Joy in Practicing Medicine November 3, 2026 Matic and ...

Michael Sloan is Vice President of Business Development at Almac Diagnostics Limited. Sloan has a BSC in commerce and MSC in corporate Leadership. Educated in the University of Birmingham, Napier ...

[1] Fenstermaker RA, Figel SA, Qiu JX, Barone TA, Dharma SS, Winograd EK, Galbo PM, Wiltsie LM, Ciesielski MJ. Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor ...

The 19th Congress of the European Hematology Association being held June 12 – 15 in Milan, Italy, the largest international hematology conference outside the United States, helps participating ...

[2] Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, et all, Charting the Future of Cancer Health Disparities Research: A Position Statement From the ...

The ICON 7 trial: OS results of bevacizumab in women with newly diagnosed ovarian cancer The ICON 6 trial: Data of anti-VEGF drug cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer The ...

David A. Dodd and Kelly T McKee, Jr., MD, MPH Checkpoint inhibitors can only amplify an antitumor immune response that already exists, which is why immunologically “cold” tumors remain one of ...

Generative AI is rapidly entering oncology, from literature review and medical writing to trial prescreening and clinical decision support. Early studies show real gains in accuracy and efficiency, ...